Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
James R. Tribble(Karolinska Institutet), Pete A. Williams(Karolinska Institutet), Marcela Votruba(University Hospital of Wales), Peter G. Fuerst(University of Idaho), Amin Otmani(Karolinska Institutet), Robert W. Burgess(Jackson Laboratory), Miriam Kolko(University of Copenhagen), Gloria Cimaglia(Karolinska Institutet), Shanshan Sun(Cardiff University), Seungsoo Rho(CHA University Bundang Medical Center), Gauti Jóhannesson(University of Iceland), Alberto Domínguez‐Vicent(Karolinska Institutet), Eirini Kokkali(Cardiff University), Sevannah A. Ellis(The University of Melbourne), Abinaya Priya Venkataraman(Karolinska Institutet), Melissa Jöe(Karolinska Institutet), Emma Lardner(Karolinska Institutet), Rupali Vohra(University of Copenhagen), Jonathan G. Crowston(The University of Melbourne), Rune Brautaset(Karolinska Institutet)
Cited by 14
Related Papers
Imaging axonal transport of mitochondria in vivo
|Nature Methods|2007|421
Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition
|Nature|2003|333
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
|Redox Biology|2021|227
Normal-Tension Glaucoma Has Normal Intracranial Pressure
|Ophthalmology|2017|97